ATLAS Score for Clostridium Difficile Infection

Loading...

Age, years

Tx w/ systemic antibiotics during C. diff infection therapy (≥ 1 day duration)

Leukocyte count, cells/uL

Serum albumin

Serum creatinine (as a measure of renal function)

References

Gregory R Madden. Predicting Clostridioides difficile infection outcomes with explainable machine learning.. EBioMedicine, 2024
Anne F Peery. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.. Gastroenterology, 2024
Rachel H. Boone. Validation of clinical risk tools for recurrent Clostridioides difficile infection. Infection Control and Hospital Epidemiology, 2024
Gregory R. Madden. Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes. Antimicrobial Agents and Chemotherapy, 2022
D. A. Perry. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021
Stuart Johnson. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021
Colleen R Kelly. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.. The American journal of gastroenterology, 2021